Thomas N. O’Connell

1.0k total citations
19 papers, 698 citations indexed

About

Thomas N. O’Connell is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Thomas N. O’Connell has authored 19 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Thomas N. O’Connell's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Thomas N. O’Connell is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Thomas N. O’Connell collaborates with scholars based in United States, United Kingdom and Italy. Thomas N. O’Connell's co-authors include R. Scott Obach, Deepak Dalvie, Jotham W. Coe, Kathleen S. Zandi, Michael J. Shapiro, Li Yu, Cornelis E. C. A. Hop, Michael P. DeNinno, Yue Chen and Gregory S. Walker and has published in prestigious journals such as Analytical Chemistry, Journal of Medicinal Chemistry and Drug Metabolism and Disposition.

In The Last Decade

Thomas N. O’Connell

19 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas N. O’Connell United States 12 367 141 129 125 111 19 698
Louis Leung United States 16 195 0.5× 124 0.9× 287 2.2× 74 0.6× 117 1.1× 24 754
Giorgio Ottaviani Switzerland 14 189 0.5× 104 0.7× 67 0.5× 144 1.2× 113 1.0× 22 635
Angelica Mazzolari Italy 16 451 1.2× 96 0.7× 103 0.8× 136 1.1× 269 2.4× 48 794
Kimberley A. Lentz United States 14 199 0.5× 78 0.6× 125 1.0× 108 0.9× 108 1.0× 24 963
Randall R. Miller United States 18 409 1.1× 103 0.7× 249 1.9× 120 1.0× 68 0.6× 27 905
Francesc Cabré Spain 18 293 0.8× 331 2.3× 99 0.8× 327 2.6× 67 0.6× 55 995
Stuart W. Paine United Kingdom 18 270 0.7× 91 0.6× 306 2.4× 187 1.5× 263 2.4× 61 993
Carmela Gnerre Switzerland 18 288 0.8× 254 1.8× 192 1.5× 374 3.0× 81 0.7× 39 1.1k
Susan Cole United Kingdom 14 276 0.8× 106 0.8× 290 2.2× 99 0.8× 200 1.8× 28 916

Countries citing papers authored by Thomas N. O’Connell

Since Specialization
Citations

This map shows the geographic impact of Thomas N. O’Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas N. O’Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas N. O’Connell more than expected).

Fields of papers citing papers by Thomas N. O’Connell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas N. O’Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas N. O’Connell. The network helps show where Thomas N. O’Connell may publish in the future.

Co-authorship network of co-authors of Thomas N. O’Connell

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas N. O’Connell. A scholar is included among the top collaborators of Thomas N. O’Connell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas N. O’Connell. Thomas N. O’Connell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bai, Guoyun, Thomas N. O’Connell, Michael A. Brodney, et al.. (2021). Intramolecular Ring-Opening Decomposition of Aryl Azetidines. ACS Medicinal Chemistry Letters. 12(10). 1585–1588. 2 indexed citations
2.
Petersen, Donna N., Julie A. Hawkins, Kimberly A. Stevens, et al.. (2016). A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation. Cell chemical biology. 23(11). 1362–1371. 68 indexed citations
3.
O’Connell, Thomas N., et al.. (2014). Solution-Based Indirect Affinity Selection Mass Spectrometry—A General Tool For High-Throughput Screening Of Pharmaceutical Compound Libraries. Analytical Chemistry. 86(15). 7413–7420. 52 indexed citations
4.
Shalaeva, Marina, Giulia Caron, Yuriy A. Abramov, et al.. (2013). Integrating Intramolecular Hydrogen Bonding (IMHB) Considerations in Drug Discovery Using ΔlogP As a Tool. Journal of Medicinal Chemistry. 56(12). 4870–4879. 73 indexed citations
5.
Efremov, Ivan, F.F. Vajdos, Kris A. Borzilleri, et al.. (2012). Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of β-Secretase (BACE1) through Fragment-Based Drug Design. Journal of Medicinal Chemistry. 55(21). 9069–9088. 50 indexed citations
6.
Kamel, Amin, et al.. (2010). Metabolism, Pharmacokinetics, and Excretion of the 5-Hydroxytryptamine1B Receptor Antagonist Elzasonan in Humans. Drug Metabolism and Disposition. 38(11). 1984–1999. 7 indexed citations
7.
Shaffer, Christopher L., Mithat Gunduz, Tim F. Ryder, & Thomas N. O’Connell. (2009). Species Differences in the Biotransformation of an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist: The Effects of Distinct Glucuronide Metabolites on Overall Compound Disposition. Drug Metabolism and Disposition. 38(2). 292–301. 5 indexed citations
8.
9.
10.
Walker, Gregory S. & Thomas N. O’Connell. (2008). Comparison of LC-NMR and conventional NMR for structure elucidation in drug metabolism studies. Expert Opinion on Drug Metabolism & Toxicology. 4(10). 1295–1305. 19 indexed citations
11.
12.
Shaffer, Christopher L., Mithat Gunduz, Thomas N. O’Connell, R. Scott Obach, & Shiyin Yee. (2005). BIOTRANSFORMATION OF A GABAA RECEPTOR PARTIAL AGONIST IN SPRAGUE-DAWLEY RATS AND CYNOMOLGUS MONKEYS: IDENTIFICATION OF TWO UNIQUE N-CARBAMOYL METABOLITES. Drug Metabolism and Disposition. 33(11). 1688–1699. 29 indexed citations
13.
Obach, R. Scott, et al.. (2005). METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO. Drug Metabolism and Disposition. 34(1). 121–130. 166 indexed citations
14.
Yu, Li, Yue Chen, Michael P. DeNinno, Thomas N. O’Connell, & Cornelis E. C. A. Hop. (2005). IDENTIFICATION OF A NOVEL GLUTATHIONE ADDUCT OF DICLOFENAC, 4′-HYDROXY-2′-GLUTATHION-DESCHLORO-DICLOFENAC, UPON INCUBATION WITH HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 33(4). 484–488. 53 indexed citations
15.
Dalvie, Deepak & Thomas N. O’Connell. (2004). CHARACTERIZATION OF NOVEL DIHYDROTHIENOPYRIDINIUM AND THIENOPYRIDINIUM METABOLITES OF TICLOPIDINE IN VITRO: ROLE OF PEROXIDASES, CYTOCHROMES P450, AND MONOAMINE OXIDASES. Drug Metabolism and Disposition. 32(1). 49–57. 43 indexed citations
16.
Sakya, Subas M., John P. Dirlam, Thomas N. O’Connell, et al.. (2001). Synthesis and structure–activity relationships of thiotetronic acid analogues of thiolactomycin. Bioorganic & Medicinal Chemistry Letters. 11(20). 2751–2754. 35 indexed citations
17.
Brown, Maria S., John P. Dirlam, Hamish A. I. McArthur, et al.. (1999). Production of 6-Deoxy-13-cyclopropyl-Erythromycin B by Saccharopolyspora erythraea NRRL 18643.. The Journal of Antibiotics. 52(8). 742–747. 8 indexed citations
18.
PACEY, MICHAEL S., John P. Dirlam, Peter F. Leadlay, et al.. (1998). Novel Erythromycins from a Recombinant Saccharopolyspora erythraea Strain NRRL 2338 pIG1. I. Fermentation, Isolation and Biological Activity.. The Journal of Antibiotics. 51(11). 1029–1034. 47 indexed citations
19.
Coe, Jotham W. & Thomas N. O’Connell. (1994). Convenient preparation of 9-cis-retinoic acid. Bioorganic & Medicinal Chemistry Letters. 4(2). 349–350. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis Leung Breakdown of academic impact, for papers by Giorgio Ottaviani Breakdown of academic impact, for papers by Angelica Mazzolari Breakdown of academic impact, for papers by Kimberley A. Lentz Breakdown of academic impact, for papers by Randall R. Miller Breakdown of academic impact, for papers by Francesc Cabré Breakdown of academic impact, for papers by Stuart W. Paine Breakdown of academic impact, for papers by Carmela Gnerre Breakdown of academic impact, for papers by Susan Cole
Rankless by CCL
2026